Olivier Delporte is an international executive with more than 20 years of sales, marketing and general management experiences, mostly in the medical devices industry.
Prior to joining Miracor Medical, Olivier was Senior Vice President, Sales & Marketing, OUS at PneumRx (acquired by BTG in 2015) and before this he led the commercial operations of Tryton Medical (now in a strategic partnership with Cordis/Cardinal Health) in Europe, Middle-East and Africa, as Vice President of Sales and Marketing. Prior to Tryton Medical he held management positions at Guidant and Abbott Vascular.
Olivier has studied and worked in the US, France, Spain, and Belgium. Besides his CEO role at Miracor Medical, Olivier is a director of Endotools Therapeutics, a start-up that has developed and commercializes minimally-invasive tools to improve gastro-enterology procedures.
Olivier earned a Masters Degree in Business from the Université Catholique de Louvain, Belgium, and an M.B.A. from the University of Chicago.
About Miracor Medical:
Miracor Medical SA is a medical device company developing disruptive solutions to treat severe heart diseases; striving to bring back cardiac patients to normal life. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops the PiCSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, a technology platform designed to improve clinical outcome of patients with impaired cardiac function. The PiCSO Therapy seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after an Acute Myocardial Infarction (AMI). Recent Clinical Studies have successfully demonstrated the positive effects of PiCSO on myocardial function and infarct size in acute heart attack patients. The PiCSO Impulse System consists of a driving console and associated catheters and offers the Heart Team new options to improve clinical outcome in Acute Myocardial Infarction patients.
Connect with Olivier Delporte
CEO, Miracor Medical